I had an
email from the clinical
and experimental immunology people today. Some interesting snippets:
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
Times Cited in 2016: 30 | Times Cited to date: 54
Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases
Times Cited in 2016: 26 | Times Cited to date: 62
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
Times Cited in 2016: 23 | Times Cited to date: 37
HIV-exposed uninfected children: a growing population with a vulnerable immune system?
Times Cited in 2016: 22 | Times Cited to date: 47
Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota
Times Cited in 2016: 17 | Times Cited to date: 33
Neutrophil extracellular traps can activate alternative complement pathways
Times Cited in 2016: 16 | Times Cited to date: 22
Helminths in the hygiene hypothesis: sooner or later?
Times Cited in 2016: 14 | Times Cited to date: 28
Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice
Times Cited in 2016: 14 | Times Cited to date: 16
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome
Times Cited in 2016: 13 | Times Cited to date: 37
Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
Times Cited in 2016: 13 | Times Cited to date: 35
Times Cited in 2016: 30 | Times Cited to date: 54
Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases
Times Cited in 2016: 26 | Times Cited to date: 62
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
Times Cited in 2016: 23 | Times Cited to date: 37
HIV-exposed uninfected children: a growing population with a vulnerable immune system?
Times Cited in 2016: 22 | Times Cited to date: 47
Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota
Times Cited in 2016: 17 | Times Cited to date: 33
Neutrophil extracellular traps can activate alternative complement pathways
Times Cited in 2016: 16 | Times Cited to date: 22
Helminths in the hygiene hypothesis: sooner or later?
Times Cited in 2016: 14 | Times Cited to date: 28
Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice
Times Cited in 2016: 14 | Times Cited to date: 16
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome
Times Cited in 2016: 13 | Times Cited to date: 37
Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
Times Cited in 2016: 13 | Times Cited to date: 35
No comments:
Post a Comment